Please assess the completion status of the following clinical trial:

Trial Title: Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
* Patients with acute leukemia, lymphoma that failed to respond or relapsed after chemotherapy or CML beyond first chronic phase.~* Patients with aplastic anemia or myelodysplasia which failed to respond to primary therapy are eligible.~* Patients with low grade lymphoma or CLL will only be eligible if they failed two chemotherapy regimens and have stage IV disease.~* Patients must be \<age 50 with a related haploidentical donor (phenotypically one, two or three HLA A, B and DR antigen mismatched) donor.~* Patients should have adequate hepatic and renal function with a bilirubin of less than or equal to 1.5mg%, SGPT less than or equal to 3x the upper limits of normal, and creatine less than or equal to 1.5mg%.~* Patients with serious intercurrent medical illness are not eligible.~* Patients and their donors must provide written informed consent.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- Megadose T cell depleted (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).